

| Revenue | $10 - $100 million See Exact Annual Revenue |
|---|---|
| Employees | 100 - 500Exact Company Size |
| Primary Industry | 5417 Scientific Research & Development Services |
| Address | 490 Arsenal Way Suite 120 Watertown, MA 02472 |
| C4 Therapeutics | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $10 - $100 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| C4 Therapeutics P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| C4 THERAPEUTICS pharmaceutical preparations for the prevention and treatment of diseases and disorders, namely, cancer and tumors; pharmaceutical preparations for the treatment of immune system related diseases and disorders | 11/16/2023 |
| TORPEDO research and development services in the field of protein degradation therapeutics | 07/13/2020 |
| BIDAC Protein degraders for the prevention and treatment of human diseases and conditions, namely, cancer, tumors, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, viral diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, enzyme deficiency diseases and disorders, and infectious diseases; pharmaceutical products for the prevention and treatment of cancer, tumors, autoimmune disorders, neurological, vascular and infectious diseases; pharmaceutical preparations for immunotherapy | 07/13/2020 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| LEIDOS | Denver, CO | 100 |
| NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
| INC RESEARCH | Raleigh, NC | 27 |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
| FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
| SYNEOS HEALTH | Raleigh, NC | 13 |
| ILLUMINA | San Diego, CA | 12 |
| UT-BATTELLE | Oak Ridge, TN | 11 |
| PRA HOLDINGS | Raleigh, NC | 11 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| ELEVATEBIO IPSC | Waltham, MA | 100 |
| IMMUNOGEN | Waltham, MA | 36 |
| BOSTON IVF | Waltham, MA | 34 |
| NPS PHARMACEUTICALS | Lexington, MA | 32 |
| CLINICAL SERVICES CORPORATE OPERATIONS | Waltham, MA | 20 |
| FOSTER-MILLER | Waltham, MA | 15 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| ADDGENE | Watertown, MA | 100 |
| TECTONIC THERAPEUTIC | Watertown, MA | 82 |
| AILERON THERAPEUTICS | Watertown, MA | 7 |
| KALA PHARMACEUTICALS | Watertown, MA | 4 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |